EUVIMEDEUVIMED entdecken
Crossref

Prussian Blue Nanozyme Featuring Enhanced Superoxide Dismutase-like Activity for Myocardial Ischemia Reperfusion Injury Treatment

Mengmeng Long, Lintao Wang, Lina Kang iD, Dongfang Liu iD, Tingting Long, He Ding, Yifan Duan, Hongliang He iD, Biao Xu, Ning Gu iD

ACS Nano · 04.02.2025 · 19 (4) · 4561-4581

DOI: 10.1021/acsnano.4c14445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 21.01.2025. Verfasst von Mengmeng Long und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Biomaterials and Devices, School of Biomedical Sciences and Medical Engineering, Southeast University, Nanjing 210096, P. …. Hauptthemen laut MEDLINE: Ferrocyanides, Myocardial Reperfusion Injury, Superoxide Dismutase, Nanoparticles. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Nanjing Science and Technology Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerrocyanidesMyocardial Reperfusion InjurySuperoxide DismutaseNanoparticlesAnimalsMiceReactive Oxygen SpeciesMale

Stichwörter der Autor:innen

Prussian blue nanozymeanti-inflammationmyocardial ischemia-reperfusion injurypolydextrose-sorbitol carboxymethyl etherreactive oxygen species

Substanzen

ferric ferrocyanideFerrocyanidesSuperoxide DismutaseReactive Oxygen Species

Autor:innen und Institutionen

  • Jiangsu Key Laboratory for Biomaterials and Devices, School of Biomedical Sciences and Medical Engineering, Southeast University, Nanjing 210096, P. R. China.
  • Department of Cardiology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu 210008, P. R. China.
  • Nanjing Key Laboratory for Cardiovascular Information and Health Engineering Medicine, Institute of Clinical Medicine, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing 210093, P. R. China.
  • Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology, Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Medical School, Zhongda Hospital, South…
  • Anqing Municipal Hospital, Anqing Medical Center of Anhui Medical University, AnQing 246003, P. R. China.

ORCID-Profile: Lina Kang, Dongfang Liu, Hongliang He, Ning Gu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Nanjing Science and Technology Development Foundation
  • Frontier Fundamental Research Program of Jiangsu Province for Leading Technology

Zitieren

APA

Long, M., Wang, L., Kang, L., Liu, D., Long, T., Ding, H., Duan, Y., He, H., Xu, B., & Gu, N. (2025). Prussian Blue Nanozyme Featuring Enhanced Superoxide Dismutase-like Activity for Myocardial Ischemia Reperfusion Injury Treatment. ACS Nano, 19(4), 4561-4581. https://doi.org/10.1021/acsnano.4c14445

Vancouver

Long M, Wang L, Kang L, Liu D, Long T, Ding H, et al. Prussian Blue Nanozyme Featuring Enhanced Superoxide Dismutase-like Activity for Myocardial Ischemia Reperfusion Injury Treatment. ACS Nano. 2025;19(4):4561-4581. doi:10.1021/acsnano.4c14445

BibTeX
@article{Long2025,
  author = {Long, Mengmeng and Wang, Lintao and Kang, Lina and Liu, Dongfang and Long, Tingting and Ding, He and Duan, Yifan and He, Hongliang and Xu, Biao and Gu, Ning},
  title = {Prussian Blue Nanozyme Featuring Enhanced Superoxide Dismutase-like Activity for Myocardial Ischemia Reperfusion Injury Treatment},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {4},
  pages = {4561--4581},
  doi = {10.1021/acsnano.4c14445}
}
Kostenlos starten →